Metabolic pathways regulating colorectal cancer initiation and progression
- PMID: 31129171
- DOI: 10.1016/j.semcdb.2019.05.018
Metabolic pathways regulating colorectal cancer initiation and progression
Abstract
Colorectal cancer (CRC) is one of the most common types of cancer worldwide. Despite recent advances in the molecular genetics of CRC, poor treatment outcomes highlight the need for a better understanding of the underlying mechanisms accounting for tumor initiation and progression. Recently, deregulation of cellular metabolism has emerged as a key hallmark of cancer. Reprogramming of core cellular metabolic pathways by cancer cells provides energy, anaplerotic precursors and reducing equivalents required to support tumor growth. Here, we review key findings implicating cancer metabolism as a major contributor of tumor initiation, growth and metastatic dissemination in CRC. We summarize the metabolic pathways governing stem cell fate in the intestine, the metabolic adaptations of proliferating colon cancer cells and their crosstalk with oncogenic signaling, and how they fulfill the energetic demands imposed by the metastatic cascade. Lastly, we discuss how some of these metabolic pathways could represent new vulnerabilities of CRC cells with the potential to be targeted.
Keywords: Colorectal cancer; Intestinal stem cells; Metabolic therapies; Metabolism; Metastasis.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.Int J Mol Sci. 2021 Jun 10;22(12):6262. doi: 10.3390/ijms22126262. Int J Mol Sci. 2021. PMID: 34200820 Free PMC article. Review.
-
Metabolic Pathways Regulating Colorectal Cancer: A Potential Therapeutic Approach.Curr Pharm Des. 2022;28(36):2995-3009. doi: 10.2174/1381612828666220922111342. Curr Pharm Des. 2022. PMID: 36154599 Review.
-
The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer.Front Pharmacol. 2021 Nov 23;12:768861. doi: 10.3389/fphar.2021.768861. eCollection 2021. Front Pharmacol. 2021. PMID: 34887764 Free PMC article. Review.
-
Mitochondrial remodeling in colorectal cancer initiation, progression, metastasis, and therapy: A review.Pathol Res Pract. 2023 Jun;246:154509. doi: 10.1016/j.prp.2023.154509. Epub 2023 May 8. Pathol Res Pract. 2023. PMID: 37182313 Review.
-
Cellular signaling pathways implicated in metastasis of colorectal cancer and the associated targeted agents.Future Oncol. 2015;11(21):2911-22. doi: 10.2217/fon.15.235. Epub 2015 Sep 28. Future Oncol. 2015. PMID: 26414153 Review.
Cited by
-
A novel fatty acid metabolism-related gene signature predicts the prognosis, tumor immune properties, and immunotherapy response of colon adenocarcinoma patients.FASEB Bioadv. 2022 Jun 13;4(9):585-601. doi: 10.1096/fba.2022-00017. eCollection 2022 Sep. FASEB Bioadv. 2022. PMID: 36089979 Free PMC article.
-
Role of Post-Translational Modifications in Colorectal Cancer Metastasis.Cancers (Basel). 2024 Feb 3;16(3):652. doi: 10.3390/cancers16030652. Cancers (Basel). 2024. PMID: 38339403 Free PMC article. Review.
-
Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer.BMC Cancer. 2022 Oct 4;22(1):1038. doi: 10.1186/s12885-022-10126-0. BMC Cancer. 2022. PMID: 36195841 Free PMC article.
-
Mutational landscape of intestinal crypt cells after long-term in vivo exposure to high fat diet.Sci Rep. 2023 Aug 26;13(1):13964. doi: 10.1038/s41598-023-41123-3. Sci Rep. 2023. PMID: 37633982 Free PMC article.
-
Interplay between Epigenetics and Cellular Metabolism in Colorectal Cancer.Biomolecules. 2021 Sep 25;11(10):1406. doi: 10.3390/biom11101406. Biomolecules. 2021. PMID: 34680038 Free PMC article. Review.